Monoamine transporter availability in Parkinson’s disease patients with or without depression

被引:0
作者
Swen Hesse
Philipp M. Meyer
Karl Strecker
Henryk Barthel
Florian Wegner
Christian Oehlwein
Ioannis Ugo Isaias
Johannes Schwarz
Osama Sabri
机构
[1] University of Leipzig,Department of Nuclear Medicine
[2] University of Leipzig,Department of Neurology
[3] Specialized Parkinson’s Disease Outpatient Centre,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2009年 / 36卷
关键词
SPECT; Dopamine; Serotonin; Striatum; Midbrain;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 255 条
  • [1] Lamberg L(2001)Psychiatric symptoms common in neurological disorders JAMA 286 154-156
  • [2] Lemke MR(2004)Depression and Parkinson’s disease J Neurol 251 VI/24-VI/27
  • [3] Fuchs G(2005)Psychiatric complications in Parkinson disease Am J Geriatr Psychiatry 13 844-851
  • [4] Gemende I(2000)SPECT and PET imaging of the dopaminergic system in Parkinson’s disease J Neurol 247 IV/2-IV/7
  • [5] Herting B(2006)Molecular imaging of the dopaminergic system and its association with human cognitive function Biol Psychiatry 59 898-907
  • [6] Oehlwein C(1995)Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson’s disease J Neurol Sci 133 73-78
  • [7] Reichmann H(2003)Systematic review of antidepressant therapies in Parkinson’s disease Parkinsonism Relat Disord 10 59-65
  • [8] Weintraub D(2001)Depression in Parkinson’s disease: its prevalence, diagnosis, and neurochemical background J Neurol 248 III5-III11
  • [9] Stern MB(1997)Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography J Neurol Neurosurg Psychiatry 63 590-596
  • [10] Brücke T(2004)Treatment of depression in Parkinson’s disease Parkinsonism Relat Disord 10 S37-S41